Clinical Trial Update: Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating lenrispodun as adjunctive therapy for motor fluctuations in Parkinson disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Lenrispodun (lenrispodun)

Snippet

Sponsor: Intra-Cellular Therapies, Inc. | Conditions: Parkinson Disease | Phase 2 | Status: RECRUITING